Header Logo

Connection

SHUBHAM PANT to Adenosine Triphosphate

Back to Details
This is a "connection" page, showing publications SHUBHAM PANT has written about Adenosine Triphosphate.
SHUBHAM PANT
Connection Strength
0.049
Adenosine Triphosphate
  1. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies. Cancer Res Commun. 2024 02 12; 4(2):378-387.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.